Profile
Kristian Borbos is currently Deputy Director at Ascelia Incentive AB and Chief Financial Officer at Gubra A since 2022.
Former roles include Chief Financial Officer at Ascelia Pharma AB from 2017 to 2022, Manager-Business Finance at Novozymes A from 2016 to 2017, and Lead Manager-Investor Relations at Ørsted A and Ørsted AB from 2009 to 2016.
Education includes graduate studies at the University of Lund.
Kristian Borbos active positions
| Companies | Position | Start |
|---|---|---|
| GUBRA A/S | Director of Finance/CFO | 2022-07-31 |
Ascelia Incentive AB | Corporate Officer/Principal | - |
Former positions of Kristian Borbos
| Companies | Position | End |
|---|---|---|
| ASCELIA PHARMA AB | Director of Finance/CFO | 2022-08-31 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | 2017-08-31 |
| ORSTED A/S | Public Communications Contact | 2016-06-30 |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Investor Relations Contact | 2016-06-30 |
Training of Kristian Borbos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Ørsted A/S
Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Utilities |
Ascelia Pharma AB
Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ascelia Incentive AB |
- Stock Market
- Insiders
- Kristian Borbos
















